Main Active Components of St. John's Wort (Hypericum Perforatum) Extracts: Current Analytical Procedures for Pharmacokinetics and Concentration-Response Studies

Publisher： Bentham Science Publishers

E-ISSN： 1875-676x|2|1|59-68

ISSN： 1573-4129

Source： Current Pharmaceutical Analysis, Vol.2, Iss.1, 2006-01, pp. : 59-68

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antidepressant-Like Components of Hypericum perforatum Extracts: An Overview of Their Pharmacokinetics and Metabolism

By  

Current Drug Metabolism, Vol. 6, Iss. 6, 2005-12 ,pp. : 531-543

Bentham Science Publishers

Access to resources Recommend Favorite

Do Other Hypericum Species Have Medical Potential As St. John's Wort (Hypericum perforatum)?

By  

Current Medicinal Chemistry, Vol. 20, Iss. 18, 2013-06 ,pp. : 2273-2295

Bentham Science Publishers

Access to resources Recommend Favorite

St John's wort (Hypericum perforatum) modulates evoked potentials in guinea pig hippocampal slices via AMPA and GABA receptors

By Langosch J.M.   Zhou X.-Y.   Heinen M.   Kupferschmid S.   Chatterjee S.S.   Noldner M.   Walden J.  

European Neuropsychopharmacology, Vol. 12, Iss. 3, 2002-06 ,pp. : 209-216

Elsevier

Access to resources Recommend Favorite

Sub-chronic treatment with an extract of Hypericum perforatum (St John's wort) significantly reduces cortisol and corticosterone in the rat brain

By Franklin M.   Reed A.   Murck H.  

European Neuropsychopharmacology, Vol. 14, Iss. 1, 2004-01 ,pp. : 7-10

Elsevier

Access to resources Recommend Favorite

The Efficacy of Hypericum perforatum (St John's Wort) for the Treatment of Premenstrual Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial

By Canning Sarah  

CNS Drugs, Vol. 24, Iss. 3, 2010-03 ,pp. : 207-225

Adis International

Access to resources Recommend Favorite